[Federal Register: November 29, 2006 (Volume 71, Number 229)]
[Notices]
[Page 69106]
[DOCID:fr29no06-37]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. RP07-71-000]

Transcontinental Gas Pipe Line Corporation, Notice of Proposed
Changes in FERC Gas Tariff

(November 21, 2006)
    Take notice that on November 17, 2006, Transcontinental Gas Pipe
Line Corporation (Transco) tendered for filing as part of its FERC Gas
Tariff, Third Revised Volume No. 1, Second Revised Thirty-Fourth
Revised Sheet No. 28, to become effective December 1, 2006.
    Transco states that copies of the filing are being mailed to
affected customers and interested state commissions.
    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211 and 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as appropriate. Such notices,
motions, or protests must be filed in accordance with the provisions of
Section 154.210 of the Commission's regulations (18 CFR 154.210).
Anyone filing an intervention or protest must serve a copy of that
document on the Applicant. Anyone filing an intervention or protest on
or before the intervention or protest date need not serve motions to
intervene or protests on persons other than the Applicant.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://www.ferc.gov.
 Persons unable to file electronically should submit an

original and 14 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street, NE., Washington, DC
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the

``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For

TTY, call<PHONE_NUMBER>.

Magalie R. Salas,
Secretary.
[FR Doc. E6-20195 Filed 11-28-06; 8:45 am]

BILLING CODE 6717-01-P


March 14 15, 2006 FIFRA Scientific Advisory Panel Regarding Scientific Issues Associated with MIR604 Modified Cry3A Protein Bt Corn Human Health and Environmental Assessments   Questions to the Panel MIR604 Environmental Assessment 1. The weight of evidence from the reviewed data indicates that there will not be a hazard to wildlife from the commercialization of Event MIR604 corn. Although the mCry3A protein expressed by Event MIR604 corn is known to affect only coleopteran insect species, EPA assessed the potential risks, to a wide variety of non target organisms ( i. e. mammals, birds, fish, invertebrates and plants), that could potentially result from exposure to this Bt protein. The emphasis of this non target risk assessment, however, was on invertebrate species that dominate corn agroecosystems. The Agency also evaluated a soil fate study that was intended to provide information on the persistence and rate of degradation of mCry3A protein in the soil environment. After reviewing data submitted in support of the Event MIR604 Bt corn registration, EPA concluded that aquatic and terrestrial wildlife, including soil organisms, were not likely to be adversely affected and that this Bt corn product is not likely to threaten the longterm survival of any non target wildlife populations.

The Panel is requested to comment on the Agency's analysis of the currently available data on the potential impacts of Event MIR604 corn on non target species.

MIR604 Human Health and Characterization ( 1) Previously submitted studies for Event MIR604 demonstrated the equivalence of the plantand bacterial produced test substances by showing similar molecular weights, purity of 90.3%, a lack of post translational glycosylation of mCry3A from either source, and comparable toxicities toward western corn rootworm ( WCRW). However, two forms of mCry3A ( designated as mCry3A sf and mCry3A lf) were found in the bacterial produced test material ( MCRY3A 0102). The molecular weights of the short and long form of mCry3A were 67.5 kDa and 69.1 kDa, respectively, determined via SDS PAGE and MALDI TOF Mass spectrometry. The lesser of the two components, with the lower molecular weight, corresponded to the intended mCry3A protein with 598 amino acids. The other component contained the same 598 amino acids as the first component but also contained an additional 16 amino acids at the N  terminal end of the protein. Both mCry3A forms were insecticidally active against WCRW. On this basis, and taking into account the high degree of structural homology ( 97.4% amino acid identity), the two forms of mCry3A in test material MCRY3A 0102 were considered to be equivalent.

Please comment on the Agency's conclusion that the mCry3A proteins from corn event MIR604 and from recombinant E. coli are substantially the same for the purpose of the Agency's risk assessment; and that the equivalence is confirmed for the two forms of the bacterial produced mCry3A test material ( MCRY3A 0102).

( 2) Previously submitted studies demonstrated the lack of toxicity of the mCry3A protein following acute oral high dose exposure to mice, rapid degradation of mCry3A upon exposure to simulated mammalian gastric fluid, and the lack of significant amino acid sequence homology of 2 the mCry3A protein to proteins known to be mammalian toxins or human allergens. Moreover, little to no human dietary exposure to mCry3A protein is expected to occur via transformed corn. Therefore, dietary exposure to mCry3A is not anticipated to pose any dietary risk to the U. S. population.

Please comment on the Agency's conclusions regarding the lack of mammalian toxicity and allergenicity of mCry3A.


April 13, 2021  -  Ozone and PM NAAQS Meeting Attendees:

From the states

Jonathan Wiener, California Attorney General's Office<EMAIL_ADDRESS>Sparsh Khandeshi, California Attorney General's Office<EMAIL_ADDRESS>Mike Myers, New York Attorney General's Office<EMAIL_ADDRESS>Claiborne Walthall, New York Attorney General's Office<EMAIL_ADDRESS>Ellen Peter, California Air Resources Board<EMAIL_ADDRESS>Craig Segall, California Air Resources Board<EMAIL_ADDRESS>Daniel Whitney, California Air Resources Board<EMAIL_ADDRESS>Kelli Johnson, California Air Resources Board<EMAIL_ADDRESS>Bonnie Holmes-Gen, California Air Resources Board<EMAIL_ADDRESS>Ann Johnston, Pennsylvania Attorney General's Office<EMAIL_ADDRESS>Nick Buttino, New York Attorney General's Office<EMAIL_ADDRESS>
From the NGOs

Seth Johnson, Earthjustice<EMAIL_ADDRESS>Marvin C. Brown IV, Earthjustice<EMAIL_ADDRESS>Rachel Fullmer, EDF<EMAIL_ADDRESS>Peter Zalzal, EDF<EMAIL_ADDRESS>Stephanie Kodish, National Parks Conservation Association<EMAIL_ADDRESS>Josh Berman, Sierra Club<EMAIL_ADDRESS>Hayden Hashimoto, Clean Air Task Force<EMAIL_ADDRESS>Ann Weeks, Clean Air Task Force<EMAIL_ADDRESS>Alan Masinter, Clean Air Task Force<EMAIL_ADDRESS>Mike Landis, Environment America<EMAIL_ADDRESS>Zach Laris, American Academy of Pediatrics<EMAIL_ADDRESS>Lucas Allen, American Academy of Pediatrics<EMAIL_ADDRESS>From the EPA
Peter Tsirigotis
Mike Koerber
Erika Sasser
Rhea Jones
Sara Terry
Karen Wesson
Deirdre Murphy
Lars Perlmutt
Nicole Hagan
Melina Williams
Sheila Igoe
David Orlin